Patients with primary glomerulonephritis have a high prevalence of atherosclerosisand endothelial dysfunction, not fully explained by traditional risk factors, butpossibly influenced by the early onset of mineral and bone disorders, marked byincreased serum levels of FGF-23 and chronic inflammation. This evidence concerns the gene FGF23 and endothelial dysfunction.